Nath Bio-Genes (India) Limited (NATHBIOGEN.NS)
Mumbai, IN
Nath Bio-Genes (India) Limited is dedicated to the development, preparation, and worldwide distribution of both hybrid and genetically modified (GM) seeds, catering to demand within India and internationally. Its business operations are organized into two main divisions: agricultural pursuits and trading endeavors. The company provides a wide array of seeds, including: Cereals: Maize, paddy, millet, wheat, and jowar. Fruits: Various fruit seed varieties. Fiber and Oil-Producing Crops: Notably cotton and mustard. Vegetables: A comprehensive selection such as chilli, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, onion, sweet pepper, green peas, pumpkin, tinda, cabbage, and French beans. Additionally, Nath Bio-Genes supplies agricultural enhancement products, offering crop protection supplements like the WINPro GOLii, WINall, and Win Chi Win growth enhancers. It also provides forage supplements, NUTRIMAX GOLD and NUTRIMAX, specifically formulated to boost fodder production. The company disseminates its products via an extensive network that includes distributors, dealers, and its own processing facilities. Nath Bio-Genes (India) Limited was founded in 1979 and is based in Aurangabad, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.60% | -1.70% | +1.73% | +16.97% | +8.56% | +7.03% | -16.73% | -10.79% | -58.69% | +84.81% | +692.48% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Agricultural Inputs: +9.5%+22.0% ★ Q1'26: -0.7% (vs Q1'25)
-
EPS growth Agricultural Inputs: +23.0%+3.3% Q1'26: -258.0% (vs Q1'25)
-
FCF margin FCF growth · Agricultural Inputs: +27.6%-9.1% Q1'26: -212.8% (vs Q1'25)
-
EBIT margin Agricultural Inputs: +9.7%+10.9% ★ Q1'26: -13.1% (vs Q1'25)
-
ROIC Agricultural Inputs: +7.4%+5.9% Q1'26: -2.2% (vs Q1'25)
-
Share dilution Agricultural Inputs: +0.0%+3.5% Q1'26: -99.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Inputs: 0.03×2.64× Q1'26: -6.07× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.31B
est: 2.41B (-4.3%)
|
2.80B
est: 2.79B (+0.2%)
|
3.07B
est: 3.33B (-7.7%)
|
2.78B
est: 3.83B (-27.3%)
|
3.01B
est: 4.49B (-32.8%)
|
2.48B
est: 5.26B (-52.9%)
|
2.41B
2.41B – 2.41B
-54.2% YoY
|
2.41B
2.41B – 2.41B
+0.0% YoY
|
2.79B
2.79B – 2.79B
+16.0% YoY
|
3.33B
3.33B – 3.33B
+19.3% YoY
|
3.83B
3.83B – 3.83B
+15.0% YoY
|
| EBITDA |
452.53M
est: 269.47M (+67.9%)
|
562.98M
est: 312.49M (+80.2%)
|
684.33M
est: 372.73M (+83.6%)
|
-497.06M
est: 428.64M (-216.0%)
|
488.91M
est: 725.50M (-32.6%)
|
536.39M
est: 591.08M (-9.3%)
|
218.98M
218.98M – 218.98M
-63.0% YoY
|
218.98M
218.98M – 218.98M
+0.0% YoY
|
253.94M
253.94M – 253.94M
+16.0% YoY
|
302.88M
302.88M – 302.88M
+19.3% YoY
|
348.32M
348.32M – 348.32M
+15.0% YoY
|
| EBIT |
438.07M
est: 243.53M (+79.9%)
|
548.45M
est: 282.41M (+94.2%)
|
646.52M
est: 336.84M (+91.9%)
|
-527.90M
est: 387.37M (-236.3%)
|
457.38M
est: 855.29M (-46.5%)
|
501.93M
est: 1.00B (-50.0%)
|
193.15M
193.15M – 193.15M
-80.8% YoY
|
193.15M
193.15M – 193.15M
+0.0% YoY
|
223.99M
223.99M – 223.99M
+16.0% YoY
|
267.17M
267.17M – 267.17M
+19.3% YoY
|
307.24M
307.24M – 307.24M
+15.0% YoY
|
| Net Income |
384.33M
est: 498.32M (-22.9%)
|
504.84M
est: 515.95M (-2.2%)
|
556.62M
est: 571.91M (-2.7%)
|
-673.38M
est: 645.51M (-204.3%)
|
350.11M
est: 811.14M (-56.8%)
|
396.19M
est: 811.71M (-51.2%)
|
515.92M
515.92M – 515.92M
-36.4% YoY
|
515.92M
515.92M – 515.92M
+0.0% YoY
|
534.17M
534.17M – 534.17M
+3.5% YoY
|
592.12M
592.12M – 592.12M
+10.8% YoY
|
668.31M
668.31M – 668.31M
+12.9% YoY
|
| SGA |
234.31M
est: 419.03M (-44.1%)
|
292.19M
est: 485.93M (-39.9%)
|
262.92M
est: 579.59M (-54.6%)
|
382.11M
est: 666.53M (-42.7%)
|
290.88M
est: 803.10M (-63.8%)
|
349.23M
est: 942.24M (-62.9%)
|
545.93M
545.93M – 545.93M
-42.1% YoY
|
545.93M
545.93M – 545.93M
+0.0% YoY
|
633.10M
633.10M – 633.10M
+16.0% YoY
|
755.13M
755.13M – 755.13M
+19.3% YoY
|
868.39M
868.39M – 868.39M
+15.0% YoY
|
| EPS |
20.22
est: 26.00 (-22.2%)
|
26.57
est: 26.92 (-1.3%)
|
29.29
est: 29.84 (-1.8%)
|
-35.43
est: 33.68 (-205.2%)
|
18.42
est: 37.67 (-51.1%)
|
20.85
est: 42.14 (-50.5%)
|
26.00
26.00 – 26.00
-38.3% YoY
|
26.00
26.00 – 26.00
+0.0% YoY
|
26.92
26.92 – 26.92
+3.5% YoY
|
29.84
29.84 – 29.84
+10.8% YoY
|
33.68
33.68 – 33.68
+12.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-06-11 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-06-10 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-06-09 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-06-08 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-06-05 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-06-04 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-06-03 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-06-02 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-06-01 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-29 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-27 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-26 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-25 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-22 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-21 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-20 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-19 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-18 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-15 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-14 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-13 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-12 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-11 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-08 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-07 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-06 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-05 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Amol Arunrao Gupta | Chief Financial Officer | 8M | male |
| Satish Kagliwal | Executive Chairman & MD | 7M | male |
| Dhiraj Rajesh Rathi | Company Secretary & Compliance Officer | 844.0K | male |
| Jeevanlata Nandkishor Kagliwal | Executive Director | 20.0K | female |
| Harish Pandey | Vice President of Marketing | — | male |
| Devinder Khurana | Executive Vice President | — | male |
| Ravinder K. Reddy | Vice President | — | male |
| Santosh Joshi | Vice President | — | — |
| Anil Khed | Vice President | — | — |
| Venkatesh N. Kulkarni | Vice President of R&D | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NATHBIOGEN.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
